Publication Topic

Flume PA, Nordyke RJ, Han D, Jha A, Nicholson G, Peipert JD. 2026. Patient-reported outcome measures developed for non-cystic fibrosis bronchiectasis may be applied to cystic fibrosis bronchiectasis. Health Qual Life Outcomes; doi: 10.1186/s12955-026-02546-4. Online ahead of print May 13. PMID: 42129785.

Beggs AH, Haselkorn T, Solomon F, Rumantir R, Bylsma LC, Vue S, Mitchell M, Kelsh M, Sacks NC, Graham RJ. Epidemiology of x-linked myotubular myopathy (XLMTM) in the United States using a machine learning model. Abstract/Poster 106S, Muscular Dystrophy Association (MDA) Clinical and Scientific Conference, Orlando, FL, March 2026.

Broome C, Hausrath D, Jaworski J, Fernandez S, Edwards T,…, Bylsma L, Kelsh M,.., Mitchell M. Survival outcomes of patients with secondary hemophagocytic lymphohistiocytosis at two academic medical centers in the United States. Poster 905, Blood 146(Sup 1):6243; doi: 10.1182/blood-2025-6243. 67^th American Society of Hematology (ASH) Annual Meeting and Exposition, Orlando, FL, November 2025.

Movva N, Bylsma L, Suh M, Kelsh M, Van Valkenburgh H, Zaha R. 2025. Systematic literature review of bioavailability of characteristics, clinical presentations, and outcomes among women with pregnancies affected by fetal and neonatal alloimmune thrombocytopenia (FNAIT) and/or have anti-HPA-1a antibodies with no history of FNAIT. PROSPERO 2025:CRD420251153257. Available from: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251153257.

Suh M, Movva N, Izikson R, La Via W, Pastula S, Machado MAA, Shin T, Rizzo C. The burden of respiratory syncytial virus among young children in the United States is not well-documented across settings: A systematic literature review. Abstract P2192, IDWeek, Atlanta GA, October 2025.

Preib MT, Emden MR, Sacks NC, Mitrani-Gold FS, Ju S, Kawano Y, Kawamatsu S, Joshi AV. 2025. Prevalence and economic evaluation of acute uncomplicated cystitis in women from Japan: A retrospective cohort study. JAC Antimicrob Resist 7(5):dlaf178; doi: 10.1093/jacamr/dlaf178. PMID: 41113066.

Johnson W, Covert K, Mitchell M, Kelsh M, Mangal B, Bose M, Dong K, Dao K-H. Real-world outcomes with available therapies in secondary hemophagocytic lymphohistiocytosis (sHLH): A natural history study with an embedded historical control arm. Poster 19, Histiocyte Society 41^st Annual Meeting, Seattle, WA, September 2025.

Shaw J, Hsu H, Tu H, Chia V, Aggarwal S, Carrigan G, Kelsh MA. Immortal time bias impacts time-to-time event outcomes in cohort with genomic testing. Abstract 6F-03, International Society for Pharmacoepidemiology (ISPE) 41^st Annual Meeting, Washington, DC, August 2025.

Pastula ST, Bylsma LC, Rege SV, Lewis RJ, Movva N. 2025. Scoping review of indices to measure a community’s health status. Popul Health Manag 28(1):37-49; doi: 10.1089/pop.2024.0138. PMID: 39558762.

Movva N, Girguis M, Bylsma L, Saleem N, Grasic K, Suh M, Pastula S, Frankenfeld C. 2025. Systematic literature review of glucagon-like peptide 1 (GLP-1) receptor agonist use among type 2 diabetes in the United States. PROSPERO 2025:CRD4202564618. Available from: https://www.crd.york.ac.uk/PROSPERO/view/CRD42025646418.